TMEM123


Summary: This gene encodes a highly glycosylated transmembrane protein with a high content of threonine and serine residues in its extracellular domain, similar to a broadly defined category of proteins termed mucins. Exposure of some cell types to anti-PORIMIN (pro-oncosis receptor inducing membrane injury) antibody, crosslinks this protein on the cell surface and induces a type of cell death termed oncosis. Oncosis is distinct from apoptosis and is characterized by a loss of cell membrane integrity without DNA fragmentation. This gene product is proposed to function as a cell surface receptor that mediates cell death. [provided by RefSeq, Jul 2008].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

GO terms in TMEM123


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF IPI GO:0005515 protein binding
MF NAS GO:0038023 signaling receptor activity
BP IEA GO:0007165 signal transduction
BP IDA GO:0070267 oncosis
CC IDA GO:0009897 external side of plasma membrane
CC NAS GO:0016021 integral component of membrane
Showing 1 to 6 of 7 rows

Gene expression in normal tissue: TMEM123

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

undefined6DNA replication1Longevity regulating pathway1Mitosis1Genome integrity1Biosynthesis of secondary metabolites1Protein stability and degradation1p53 pathway1PI3K/MTOR signaling1

Pathways in TMEM123


Loading, please wait...
Database
Pathway ID
Pathway Des.
No matching records found

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD366 PI-103 2
iGMDRD314 Tanespimycin 3
iGMDRD872 BRD7137 4
iGMDRD871 BRD6368 6
Showing 1 to 4 of 14 rows rows per page

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TMEM123

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​